Richard W. Dugan
Directeur/Membre du Conseil chez VANDA PHARMACEUTICALS INC.
Fortune : 437 696 $ au 30/04/2024
Postes actifs de Richard W. Dugan
Sociétés | Poste | Début | Fin |
---|---|---|---|
VANDA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/12/2005 | - |
Independent Dir/Board Member | 01/12/2005 | - |
Historique de carrière de Richard W. Dugan
Anciens postes connus de Richard W. Dugan
Sociétés | Poste | Début | Fin |
---|---|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Directeur/Membre du Conseil | 01/09/2003 | 03/08/2010 |
Critical Therapeutics, Inc. | Directeur/Membre du Conseil | 01/04/2004 | 04/11/2008 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1976 | 01/09/2002 |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Directeur/Membre du Conseil | 01/12/2005 | - |
Formation de Richard W. Dugan
The Pennsylvania State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Irlande | 2 |
Opérationnelle
Director/Board Member | 4 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
VANDA PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Critical Therapeutics, Inc. | Health Technology |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Richard W. Dugan
- Expérience